BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37964263)

  • 1. Ovarian dysfunction in adolescent girls with autoimmune rheumatic diseases.
    Taman M; Nm EH; Yousef H; Mosa DM
    Pediatr Rheumatol Online J; 2023 Nov; 21(1):138. PubMed ID: 37964263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 quarantine in adolescents with autoimmune rheumatic diseases: mental health issues and life conditions.
    Ihara BP; Lindoso LM; Setoue DND; Tanigava NY; Helito AC; Simon JR; Viana VSL; Strabelli CAA; Pedroso CAA; Sieczkowska SM; Pereira RMR; Aikawa NE; Kozu KT; Elias AM; Buscatti IM; Gualano B; Queiroz LB; Casella CB; Polanczyk GV; Silva CAA; Campos LMMA
    Clin Rheumatol; 2022 Oct; 41(10):3189-3198. PubMed ID: 35701628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review exploring the bidirectional relationship between puberty and autoimmune rheumatic diseases.
    de Gruijter NM; Naja M; Peckham H; Radziszewska A; Kinsella M; Glenister J; Rosser EC; Butler GE; Jury EC; Ciurtin C
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):47. PubMed ID: 33781271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA).
    Stagi S; Cavalli L; Bertini F; Signorini C; Matucci Cerinic M; de Martino M; Brandi ML; Falcini F
    Lupus; 2014 Nov; 23(13):1392-406. PubMed ID: 25074873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
    Massias JS; Smith EMD; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
    Lupus; 2020 Apr; 29(5):474-481. PubMed ID: 32233733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.
    Ruperto N; Ravelli A; Murray KJ; Lovell DJ; Andersson-Gare B; Feldman BM; Garay S; Kuis W; Machado C; Pachman L; Prieur AM; Rider LG; Silverman E; Tsitsami E; Woo P; Giannini EH; Martini A; ;
    Rheumatology (Oxford); 2003 Dec; 42(12):1452-9. PubMed ID: 12832713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis.
    Lythgoe H; Morgan T; Heaf E; Lloyd O; Al-Abadi E; Armon K; Bailey K; Davidson J; Friswell M; Gardner-Medwin J; Haslam K; Ioannou Y; Leahy A; Leone V; Pilkington C; Rangaraj S; Riley P; Tizard EJ; Wilkinson N; Beresford MW;
    Lupus; 2017 Oct; 26(12):1285-1290. PubMed ID: 28361566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients.
    Aikawa NE; Jesus AA; Liphaus BL; Silva CA; Carneiro-Sampaio M; Viana VS; Sallum AM
    Clin Exp Rheumatol; 2012; 30(1):126-31. PubMed ID: 22261392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraception for adolescents with chronic rheumatic diseases.
    Lourenço B; Kozu KT; Leal GN; Silva MF; Fernandes EG; França CM; Souza FH; Silva CA
    Rev Bras Reumatol Engl Ed; 2017; 57(1):73-81. PubMed ID: 28137405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
    Furia FF; Godfrey E; Mwamanenge N; Swai P
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):30. PubMed ID: 32245494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort.
    Said MA; Silva LSTE; de Oliveira Rocha AM; Alves GGB; Piotto DGP; Len CA; Terreri MT
    Adv Rheumatol; 2020 Nov; 60(1):53. PubMed ID: 33153496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate dietary intake of children and adolescents with juvenile idiopathic arthritis and systemic lupus erythematosus.
    Caetano MC; Ortiz TT; Terreri MT; Sarni RO; Silva SG; Souza FI; Hilário MO
    J Pediatr (Rio J); 2009; 85(6):509-15. PubMed ID: 19865782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor agreement of objectively measured and self-reported physical activity in juvenile dermatomyositis and juvenile systemic lupus erythematosus.
    Pinto AJ; Roschel H; Benatti FB; de Sá Pinto AL; Sallum AM; Silva CA; Gualano B
    Clin Rheumatol; 2016 Jun; 35(6):1507-14. PubMed ID: 27021334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases.
    Reis J; Aguiar F; Brito I
    Acta Reumatol Port; 2016; 41(1):45-55. PubMed ID: 27115107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease.
    Aikawa NE; Campos LM; Silva CA; Carvalho JF; Saad CG; Trudes G; Duarte A; Miraglia JL; Timenetsky Mdo C; Viana VS; França IL; Bonfa E; Pereira RM
    J Rheumatol; 2012 Jan; 39(1):167-73. PubMed ID: 22089462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of 13 cases with pediatric rheumatic disease combined with endocrine disorder].
    Hou J; Song FY; Xu YJ; Su GX; Kang M; Li SN; Wu FQ; Zhou ZX; Lai JM
    Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):865-870. PubMed ID: 34587684
    [No Abstract]   [Full Text] [Related]  

  • 18. Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).
    Torrente-Segarra V; Salman Monte TC; Rúa-Figueroa I; Sánchez-Alonso F; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Olivé-Marqués A; Ibañez-Ruán J; Horcada L; Sánchez-Atrio A; Montilla C; Melero González RB; Díez-Álvarez E; Martinez-Taboada V; Andreu JL; Fernández-Berrizbeitia O; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pecondón-Español Á; Marras C; Bonilla G; Pego-Reigosa JM;
    Clin Exp Rheumatol; 2017; 35(6):1047-1055. PubMed ID: 28628467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of paediatric rheumatic diseases in Nigeria.
    Olaosebikan BH; Adelowo OO; Animashaun BA; Akintayo RO
    Pediatr Rheumatol Online J; 2017 Jan; 15(1):7. PubMed ID: 28143550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil cytosolic factor 2 (NCF2) gene polymorphism is associated with juvenile-onset systemic lupus erythematosus, but probably not with other autoimmune rheumatic diseases in children.
    Bakutenko IY; Haurylchyk ID; Nikitchenko NV; Sechko EV; Kozyro IA; Tchitchko AM; Batyan GM; Sukalo AV; Ryabokon NI
    Mol Genet Genomic Med; 2022 Jan; 10(1):e1859. PubMed ID: 34971477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.